Advertisement
Singapore markets close in 1 hour 29 minutes
  • Straits Times Index

    3,277.77
    -9.98 (-0.30%)
     
  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     
  • Hang Seng

    17,648.38
    +363.84 (+2.10%)
     
  • FTSE 100

    8,131.43
    +52.57 (+0.65%)
     
  • Bitcoin USD

    64,489.97
    +224.82 (+0.35%)
     
  • CMC Crypto 200

    1,387.08
    -9.46 (-0.68%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • Dow

    38,085.80
    -375.12 (-0.98%)
     
  • Nasdaq

    15,611.76
    -100.99 (-0.64%)
     
  • Gold

    2,357.00
    +14.50 (+0.62%)
     
  • Crude Oil

    84.16
    +0.59 (+0.71%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • FTSE Bursa Malaysia

    1,574.28
    +5.03 (+0.32%)
     
  • Jakarta Composite Index

    7,106.20
    -49.10 (-0.69%)
     
  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Analyst Recommendations for Nektar Therapeutics in November 2017

In 3Q17, Nektar Therapeutics (NKTR) reported revenues of $152.9 million, a YoY rise of 320.7%. The sudden spurt is mainly due to the upfront payment of $150 million from Eli Lilly.